Related Experiment Video
Updated: Aug 21, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
The role of pneumolysin in pneumococcal pneumonia and meningitis
R A Hirst1, A Kadioglu, C O'callaghan
1Department of Infection, Inflamation and Immunity, University of Leicester, Leicester, UK. rah9@le.ac.uk
Abstract:
Diseases caused by Streptococcus pneumoniae include pneumonia, septicaemia and meningitis. All these are associated with high morbidity and mortality. The pneumococcus can colonize the nasopharynx, and this can be a prelude to bronchopneumonia and invasion of the vasculature space. Proliferation in the blood can result in a breach of the blood-brain barrier and entry into the cerebrospinal fluid (CSF) where the bacteria cause inflammation of the meningeal membranes resulting in meningitis. The infected host may develop septicaemia and/or meningitis secondary to bronchopneumonia. Also septicaemia is a common precursor of meningitis. The mechanisms surrounding the sequence of infection are unknown, but will be dependent on the properties of both the host and bacterium. Treatment of these diseases with antibiotics leads to clearance of the bacteria from the infected tissues, but the bacteriolytic nature of antibiotics leads to an acute release of bacterial toxins and thus after antibiotic therapy the patients can be left with organ-specific deficits. One of the main toxins released from pneumococci is the membrane pore forming toxin pneumolysin. Here we review the extensive studies on the role of pneumolysin in the pathogenesis of pneumococcal diseases.
Insights
Streptococcus pneumoniae causes severe diseases like meningitis. This review explores how pneumolysin, a bacterial toxin, contributes to the severity and long-term effects of pneumococcal infections.
Area of Science:
- Microbiology
- Immunology
- Pathogenesis
Background:
- Streptococcus pneumoniae causes pneumonia, septicaemia, and meningitis, leading to significant morbidity and mortality.
- Nasopharyngeal colonization by S. pneumoniae can precede invasive diseases like bronchopneumonia and meningitis.
- Antibiotic treatment can cause toxin release, potentially leading to organ damage.
Purpose of the Study:
- To review the role of pneumolysin in the pathogenesis of pneumococcal diseases.
- To understand the mechanisms by which pneumolysin contributes to disease severity and host deficits.
- To consolidate current knowledge on pneumolysin's impact during S. pneumoniae infections.
Main Methods:
- Literature review of studies on Streptococcus pneumoniae and pneumolysin.
- Analysis of research on pneumolysin's function in bacterial pathogenesis.
- Synthesis of findings on pneumolysin's role in host-pathogen interactions.
Main Results:
- Pneumolysin is a key toxin released from S. pneumoniae.
- This toxin contributes to inflammation and tissue damage in pneumococcal diseases.
- Pneumolysin plays a significant role in the pathogenesis and potential long-term sequelae.
Conclusions:
- Pneumolysin is a critical factor in the pathogenesis of Streptococcus pneumoniae infections.
- Understanding pneumolysin's mechanisms is crucial for developing better therapeutic strategies.
- Further research into pneumolysin may mitigate antibiotic-induced host damage.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment

